No Data
No Data
Volume change rate ranking (9 o'clock) ~ Birrott, Shimamura etc. ranked in.
※ In the volume change rate ranking, you can understand the interests of market participants such as trends in market sentiment by comparing the average volume of the last 5 days with the volume on the day of delivery. ■ Top volume change rate [as of 9:32 on October 1] (comparison with average volume of the last 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate <5616> Amefurisun 738,300 107,185.08 257.02% 0.133
INTLOOP [Emerging Markets Ratings List]
"TOHKAI Tokyo" <9556> INTLOOP OUTPERFORM Stay * The ratings of the above companies were confirmed by us as of 09/30."
Individual investor・Limited entertainer Tamisuke: Aim for stocks that maintain the trend with high performance expectations [FISCO social reporter]
The following is a comment written by individual investor Mr. Yugentei Tamisuke, a FISCO Social Reporter (Blog: Profitable Stock Information 'Nekodanna's Stocks Know No Limits'). At FISCO, we strive to collaborate with individuals who actively disseminate information to deliver a wider range of information to investors. -----------*Written at 3:00 PM on September 22, 2024, as of September, it has finally started to feel like autumn, but the sweaty lingering summer heat continues. japan
Stocks that moved the previous day part1: Kaiom, Jayck, Grandies, etc.
Stocks that moved the previous day part1: Kayoum, Jekk, Grandees, and other stocks <Code> 25th closing price ⇒ Previous day comparison J Front <3086> 1534.5 +18.25 Revised upwards the performance and dividend estimates for the fiscal year ending February 2025. After opening high, it lost momentum. GENDA <9166> 2373 -134 Profit-taking sales dominant despite confirmation of Leo's 5.17% shareholding. Kayoum <4583> 114 +2 Business partnership with Merck & Co. in antibody production outsourcing services, etc. Jekk <7073> 2310
Emerging markets stock digest: GENDA continues to decline significantly, while Jayck rebounds significantly.
<9166> GENDA 2373 -134 significantly continues to decline. Leos Capital Works, a subsidiary of SBI Reos Hifumi <165A> (Chiyoda-ku, Tokyo), has revealed in a large shareholding report based on the 5% rule that they hold 5.17% (3,930,9800 shares) of GENDA stock. In the morning, buying took the lead, but later profit-taking selling prevailed. The obligation to report occurred on the 13th, with the purpose of holding being "investment trust agreement" and "investment trust agreement commission" based net.
Hot stocks digest (morning session): Nisshin Pharmaceutical, CYBOZU, Shiseido Company,Limited Sponsored ADR, etc.
Nisshin Pharma <4516>: 3830 yen (+442 yen) significantly extended. J&J has announced that it has obtained manufacturing and sales approval for the combination drug "Yubanshi Combination Tablets", which combines the endothelin receptor antagonist macitentan 10mg and the phosphodiesterase 5 inhibitor tadalafil 40mg, for the treatment of pulmonary arterial hypertension. Positive movements towards expanding into the field of pulmonary hypertension, which is positioned as one of the areas of focus, are taking the lead. shiseido company,limited sponsored adr <4911>
No Data
No Data